Congenica Company
Congenica is a biotechnology company that provides a diagnostic decision support platform. They have translated this research into the gold standard clinical genomic analytics platform, Sapientia, providing integration of human DNA sequences with deep clinical phenotyping, enabling clinicians to provide an actionable interpretation of genetic disease for patients. It was founded in 2013 and headquartered in Cambridge, Cambridgeshire.
Total Funding:
82364942
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Funding Status:
Late Stage Venture
Estimated Revenue:
2.64
Last Funding Type:
Series C
Number Of Exists:
11-50
Last Funding Date:
2021-03-04
Investors Number:
14
Founded Date:
2012-01-01
Industry:
Omics-Based Biomarkers